This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2B Lamarche , A Tchernof , S Moorjani , B Cantin , GR Dagenais , PJ Lupien & JP Despres (1997) Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 95, 69–75.
3AC St Pierre , IL Ruel , B Cantin , GR Dagenais , PM Bernard , JP Despres & B Lamarche (2001) Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation 104, 2295–2299.
7SP Zhao , L Hollaar , FM ’t Hooft , AH Smelt , JA Gevers & LA van der Leuven (1991) Effect of simvastatin on the apparent size of LDL particles in patients with type IIB hyperlipoproteinemia. Clin Chim Acta 203, 109–117.
8JN Yuan , MY Tsai , J Hegland & DB Hunninghake (1991) Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans. Atherosclerosis 87, 147–157.
9LF Forster , G Stewart , D Bedford , JP Stewart , E Rogers , J Shepherd , CJ Packard & MJ Caslake (2002) Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates. Atherosclerosis 164, 129–145.
10M Guerin , P Egger , C Soudant , W Le Goff , A van Tol , R Dupuis & MJ Chapman (2002) Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux. Atherosclerosis 163, 287–296.
11W Marz , H Scharnagl , C Abletshauser , MM Hoffmann , A Berg , J Keul , H Wieland & MW Baumstark (2001) Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotype. Circulation 103, 1942–1948.
12HR Superko , RM Krauss & C DiRicco (1997) Effect of fluvastatin on low-density lipoprotein peak particle diameter. Am J Cardiol 80, 78–81.
13M Tilly-Kiesi (1991) The effect of lovastatin treatment on low-density lipoprotein hydrated density distribution and composition in patients with intermittent claudication and primary hypercholesterolemia. Metabolism 40, 623–628.
15 (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285, 2486–2497.
16RM Krauss , RH Eckel , B Howard , (2000) AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 102, 2284–2299.
20A Charest , C Vanstone , MP St Onge , W Parson , PJ Jones & B Lamarche (2005) Phytosterols in nonfat and low-fat beverages have no impact on the LDL size phenotype. Eur J Clin Nutr 59, 801–804.
26KA Varady , AC St Pierre , B Lamarche & P Jones (2005) Effect of plant sterols and endurance training on LDL particle size and distribution in previously sedentary hypercholesterolemic adults. Eur J Clin Nutr 59, 518–525.
30TP Erlinger , ERIII Miller , J Charleston & LJ Appel (2003) Inflammation modifies the effects of a reduced-fat low-cholesterol diet on lipids: results from the DASH-sodium trial. Circulation 108, 150–154.
33DJ Jenkins , CW Kendall , D Faulkner , (2002) A dietary portfolio approach to cholesterol reduction: combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia. Metabolism 51, 1596–1604.
34TA Pearson , GA Mensah , RW Alexander , (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107, 499–511.
35JS Yudkin , M Kumari , SE Humphries & V Mohamed-Ali (2000) Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148, 209–214.